View Larger
Lumir Lab has established a world-leading position in the development of cannabinoid-based therapeutics through clinical validation and analytical methods and offers a wide range of solutions for companies and organisations operating in the medical cannabis industry. Led by Prof. Lumír Ondřej Hanuš, a world renowned analytic chemist of 48 years with a focus on cannabinoids research and the first one to isolate the first endocannabinoid in the human brain, Anandamide.
In seeking to implement quality standards, Lumir Lab has developed an international network of respected scientists in the cannabinoid field, and has also assembled a large in-house team with extensive experience in developing cannabinoid-based treatments, medicines containing controlled substances, as well as pharmaceutical product formulation.
The lab maintains the highest levels of quality including state-of-the-art analytical technology, and unmatched testing capabilities. Each test performed is conducted in adherence to the most stringent quality control protocols in the industry.
As part of the Lumir Lab world-class standards, trials, and services, Lumir lab provide Evidence-Based Solutions, Clinical Validations, Custom Product Formulations, Cannabinoids & Terpenes Profiling, and Product Compliance.
View Larger
Prof. Lumír Ondřej Hanuš and Dr. Sari Prutchi Sagiv, Lumir Lab.
View Larger
Prof. Lumír Ondřej Hanuš at work, Lumir Lab.
View Larger
Inside the laboratory, Lumir Lab.
View Larger
Prof. Lumír Ondřej Hanuš at work, Lumir Lab.
View Larger
Prof. Lumír Ondřej Hanuš at work, Lumir Lab.
View Larger
The view from Jerusalem Biotechnology Park, Hebrew University.